InvestorsHub Logo
Followers 23
Posts 994
Boards Moderated 0
Alias Born 08/22/2013

Re: Cognition post# 5351

Thursday, 07/09/2015 10:32:31 AM

Thursday, July 09, 2015 10:32:31 AM

Post# of 9810
SNGX: ThermoVax™ Addresses Critical Concerns for Industry and Government


By Grant Zeng, CFA

OBB:SNGX

Soligenix (SNGX) is a late-stage development biopharmaceutical company focused on cancer supportive care, GI disorders as well as biodefense. The Company holds three platform technologies: the SGX94 IDR (Innate Defense Regulator) platform, the oral BDP platform and ThermoVax platform. Based on these technologies, Soligenix has built a diversified pipeline with potential to target multiple indications.

Etc. etc. go look it up...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News